Disseminated cryptococcosis, invasive aspergillosis, and mucormycosis in a patient treated with alemtuzumab for chronic lymphocytic leukaemia. (March 2014)

• Record Type: Journal Article
• Authors: Henn, Aurélia; Mellon, Guillaume; Henry, Benoît; Roos-Weil, Damien; Jauréguiberry, Stéphane; Mordant, Pierre; Fekkar, Arnaud; Caumes, Eric
• Is Part Of: Scandinavian journal of infectious diseases. Volume 46:Number 3(2014:Mar.)
• Page Start: 231
• Page End: 234
• Publication Date: 2014-03
• Subjects: Communicable diseases -- Periodicals; Infection -- Periodicals; 616.9
• DOI: 10.3109/00365548.2013.866269
• Languages: English
• ISSNs: 0036-5548

Abstract

<abstract> <title>Abstract</title> <p>We report the case of a 42-y-old man treated with alemtuzumab for chronic lymphocytic leukaemia, who developed 3 successive deep fungal infections. Despite being treated with liposomal amphotericin B and 5-flucytosine for disseminated cryptococcosis, he developed pulmonary invasive aspergillosis, followed by pulmonary mucormycosis. Several deep fungal infections may occur in association in an immunocompromised host after treatment with alemtuzumab.</p> </abstract>